Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H8N4O4 |
Molecular Weight | 200.1521 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(COC(N)=O)=NC=C1[N+]([O-])=O
InChI
InChIKey=PQFRTXSWDXZRRS-UHFFFAOYSA-N
InChI=1S/C6H8N4O4/c1-9-4(3-14-6(7)11)8-2-5(9)10(12)13/h2H,3H2,1H3,(H2,7,11)
Ronidazole is an antiprotozoal agent. Ronidazole and the other nitroimidazole derivatives damage DNA following reduction of the nitro group. It is used in veterinary for prevention and treatment of various infections including histomoniasis in turkeys, trichomoniasis in pigeons, genital trichomoniasis in cattle, haemorrhagic enteritis in pigs and Tritrichomonas foetus in cats.
Originator
Sources: https://patents.google.com/patent/US3450710 |https://patents.google.com/patent/US3459764
Curator's Comment: references retrieved from www.drugfuture.com/chemdata/ronidazole.html # Merck Sharp & Dohme Corp
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Deoxyribonucleic acid (CHEBI:16991) |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseAntiprotozoal agent used for prevention and treatment of various infections including histomoniasis in turkeys, trichomoniasis in pigeons, genital trichomoniasis in cattle, haemorrhagic enteritis in pigs and Tritrichomonas foetus in cats |
PubMed
Title | Date | PubMed |
---|---|---|
Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. | 1995 Jun |
|
Validation of a method for the detection and confirmation of nitroimidazoles and corresponding hydroxy metabolites in turkey and swine muscle by means of gas chromatography-negative ion chemical ionization mass spectrometry. | 2001 Sep 15 |
Patents
Sample Use Guides
Ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22024820
The activities of antiprotozoal compounds at concentrations ranging from 2 μg/ml to 500 μg/ml were determined via cell counts of D. fragilis trophozoites grown in dixenic culture. Ronidazole has Minimum lethal concentration (MLC), 8 to 16 μg/ml
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP51AA08
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
757865
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
7681-76-7
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
2356
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
SUB10377MIG
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
D012385
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
C152248
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL290299
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
DTXSID6045400
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
1535498
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
231-675-1
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
RONIDAZOLE
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
E01R4M1063
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
m9655
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
141154
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
5094
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
E01R4M1063
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY | |||
|
100000084357
Created by
admin on Fri Dec 15 15:24:23 GMT 2023 , Edited by admin on Fri Dec 15 15:24:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY